Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+3.6%
5Y CAGR+2.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+3.6%/yr
vs +4.6%/yr prior
5Y CAGR
+2.7%/yr
Consistent
Acceleration
-0.9pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$59.14M-13.6%
2025$68.48M-4.5%
2024$71.70M+35.0%
2023$53.13M-15.8%
2022$63.07M+21.9%
2021$51.73M+40.4%
2020$36.84M-17.1%
2019$44.45M+35.8%
2018$32.73M-17.5%
2017$39.69M-